HomeCompareRHCO vs MRK

RHCO vs MRK: Dividend Comparison 2026

RHCO yields 6666.67% · MRK yields 2.76%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 RHCO wins by $1028095347812062.00M in total portfolio value
10 years
RHCO
RHCO
● Live price
6666.67%
Share price
$0.03
Annual div
$2.00
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$1028095347812062.00M
Annual income
$998,628,545,336,266,700,000.00
Full RHCO calculator →
MRK
Merck & Co. Inc.
● Live price
2.76%
Share price
$120.31
Annual div
$3.32
5Y div CAGR
32.7%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$56.8K
Annual income
$9,798.13
Full MRK calculator →

Portfolio growth — RHCO vs MRK

📍 RHCO pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodRHCOMRK
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, RHCO + MRK cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
RHCO pays
MRK pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

RHCO
Annual income on $10K today (after 15% tax)
$566,666.67/yr
After 10yr DRIP, annual income (after tax)
$848,834,263,535,826,600,000.00/yr
MRK
Annual income on $10K today (after 15% tax)
$234.56/yr
After 10yr DRIP, annual income (after tax)
$8,328.41/yr
At 15% tax rate, RHCO beats the other by $848,834,263,535,826,600,000.00/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of RHCO + MRK for your $10,000?

RHCO: 50%MRK: 50%
100% MRK50/50100% RHCO
Portfolio after 10yr
$514047673906031.00M
Annual income
$499,314,272,668,133,360,000.00/yr
Blended yield
97.13%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on MRK right now

RHCO
No analyst data
Altman Z
3.2
Piotroski
7/9
MRK
Analyst Ratings
25
Buy
11
Hold
1
Sell
Consensus: Buy
Price Target
$128.54
+6.8% upside vs current
Range: $100.00 — $150.00
Altman Z
4.0
Piotroski
6/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

RHCO buys
0
MRK buys
0
No recent congressional trades found for RHCO or MRK in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricRHCOMRK
Forward yield6666.67%2.76%
Annual dividend / share$2.00$3.32
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR0%32.7%
Portfolio after 10y$1028095347812062.00M$56.8K
Annual income after 10y$998,628,545,336,266,700,000.00$9,798.13
Total dividends collected$1026118102492338.88M$28.9K
Payment frequencyquarterlyquarterly
SectorStockHealthcare

Year-by-year: RHCO vs MRK ($10,000, DRIP)

YearRHCO PortfolioRHCO Income/yrMRK PortfolioMRK Income/yrGap
1← crossover$677,367$666,666.67$11,206$366.19+$666.2KRHCO
2$42,928,313$42,203,530.63$12,650$502.35+$42.92MRHCO
3$2,545,616,701$2,499,683,405.64$14,407$694.19+$2545.60MRHCO
4$141,255,910,403$138,532,100,533.89$16,585$967.82+$141255.89MRHCO
5$7,335,374,338,812$7,184,230,514,680.15$19,342$1,363.89+$7335374.32MRHCO
6$356,516,885,536,661$348,668,034,994,132.70$22,913$1,947.19+$356516885.51MRHCO
7$16,218,956,689,966,618$15,837,483,622,442,392.00$27,662$2,823.89+$16218956689.94MRHCO
8$690,711,023,145,868,900$673,356,739,487,604,600.00$34,159$4,173.35+$690711023145.83MRHCO
9$27,539,067,734,387,980,000$26,800,006,939,621,900,000.00$43,337$6,308.80+$27539067734387.93MRHCO
10$1,028,095,347,812,062,000,000$998,628,545,336,266,700,000.00$56,776$9,798.13+$1028095347812062.00MRHCO

RHCO vs MRK: Complete Analysis 2026

RHCOStock

Readen Holding Corp., through its subsidiaries, operates in the telecommunications, on line music and video, and recycling industries in the Netherlands and internationally. It engages in the purchase and production-planning, and the communication with hardware and application developers; purchases and distributes plastic products used in the recycling industry; owns a hotel and estates; sells and markets labels, prepaid vouchers, and simcards, as well as engages in physical and electronic distribution via terminals to retailers and distributors; and delivers glassfiber, Internet, VoIP, mobile, TVIP, PoIP, AoIP, and online services in the cloud and e-view managed energy. The company also offers glassfiber networks on an open bases for active operators and service providers; provides online music records that are distributed as MP3 files; engages in ship management and supply; trades in non-dairy products; produces and distributes a range of infant milk formulas; and supplies stable isotopes, deuterated solvents, and high purity materials for medical and chemical research. Readen Holding Corp is headquartered in Kortenhoef, the Netherlands.

Full RHCO Calculator →

MRKHealthcare

Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, such as preventive pediatric, adolescent, and adult vaccines. The Animal Health segment discovers, develops, manufactures, and markets veterinary pharmaceuticals, vaccines, and health management solutions and services, as well as digitally connected identification, traceability, and monitoring products. It serves drug wholesalers and retailers, hospitals, and government agencies; managed health care providers, such as health maintenance organizations, pharmacy benefit managers, and other institutions; and physicians and physician distributors, veterinarians, and animal producers. The company has collaborations with AstraZeneca PLC; Bayer AG; Eisai Co., Ltd.; Ridgeback Biotherapeutics; and Gilead Sciences, Inc. to jointly develop and commercialize long-acting treatments in HIV. Merck & Co., Inc. was founded in 1891 and is headquartered in Kenilworth, New Jersey.

Full MRK Calculator →
📬

Get this RHCO vs MRK comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

RHCO vs SCHDRHCO vs JEPIRHCO vs ORHCO vs KORHCO vs MAINRHCO vs JNJRHCO vs ABBVRHCO vs PFE

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.